covid 19 News and Research

RSS

Research suggests profound SARS-CoV-2 mutations are rare even among immunosuppressed

A recent article posted to the medRxiv* preprint server assessed whether host traits like immunosuppression aids severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutational drift.

16 Jun 2022

Study confirms heightened protection from Omicron-associated hospitalizations by COVID boosters

In a recent article posted to the medRxiv* preprint server, scientists assessed the efficacy of the primary and boosted regimens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations in preventing SARS-CoV-2 Omicron-linked hospitalizations in the United States (US).

16 Jun 2022

Nasopharyngeal microbiota influences SARS-CoV-2 infection status and severity

In a recent study posted to the medRxiv* pre-print server, Canadian researchers investigated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection altered the microbiota composition of the host’s nasopharyngeal region.

16 Jun 2022

Multiomics identifies genomic risk factors for COVID-19

In a recent Cell Systems study, researchers utilized the RefMap machine learning algorithm to correlate known genomic variations for severe COVID-19 obtained from large-scale genome-wide association studies (GWAS) with single-cell multiome profiling of human lungs.

16 Jun 2022

Obesity causes COVID vaccines to lose their efficacy more rapidly

In a recent study posted to the medRxiv* pre-print server, researchers examined a clinical cohort of severely obese people vaccinated with coronavirus disease 2019 (COVID-19) vaccines to determine the relationship between an individual's body mass index (BMI) and COVID-19-related hospitalization and mortality.

16 Jun 2022

Study tracks neurological symptoms in COVID-19 "long-haulers"

Researchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurological symptoms in COVID-19 "long-haulers."

16 Jun 2022

Vaccination provides good but temporary protection against SARS-CoV-2 omicron infection, study shows

A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 omicron variant, according to a study from researchers at Weill Cornell Medicine—Qatar.

16 Jun 2022

Evidence COVID in pregnancy can affect offspring's neurodevelopment

In a recent study published in the Jama Network Open journal, researchers investigated the impact of in utero exposure to coronavirus disease 2019 (COVID-19) on the neurodevelopment of infants.

15 Jun 2022

Countries with female leaders recorded fewer COVID-19 deaths, study finds

Countries with female leaders recorded 40 per cent fewer COVID-19 deaths than nations governed by men, according to University of Queensland research.

15 Jun 2022

Loss of a grandmother may have repercussions for the loved ones she leaves behind

Losing a beloved family member is never easy, but a new study suggests the loss of a grandmother in particular may have repercussions for the loved ones she leaves behind.

15 Jun 2022

Implementing practical surface SARS-CoV-2 surveillance in public health labs and schools

Surface sampling for SARS-CoV-2 RNA has shown promise to detect the exposure of environments to infected individuals shedding the virus who would not otherwise be detected.

15 Jun 2022

Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

15 Jun 2022

People with mental health problems at higher risk for severe COVID-19 outcomes

In a recent study published in the CDC’s Emerging Infectious Diseases journal, researchers assessed the associations between mental health conditions (MHCs) and severe outcomes of coronavirus disease 2019 (COVID-19).

15 Jun 2022

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM).

15 Jun 2022

More than 1,000 genes linked to severe COVID-19 identified

Since the start of the coronavirus pandemic, scientists and clinicians have struggled to understand why some people with the infection become seriously ill or die while others have few, if any, symptoms.

15 Jun 2022

Flexible model of care can be effective in treating opioid use disorder

Did you know that more than 26,500 Canadians died from opioid intoxication between January 2016 and September 2021? Or that more than 350,000 people who used drugs containing opioids to relieve their pain did so problematically?

15 Jun 2022

Survey data provides insights into how many students are experiencing long COVID

New data from the School Infection Survey (SIS) showed that 1.8% of primary school pupils and 4.8% of secondary school pupils experienced long COVID following their most recent COVID-19 infection (since March 2020).

15 Jun 2022

Affordable Advanced Rapid Diagnostics from Global Access Diagnostics (GADx)

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx).

From Global Access Diagnostics 15 Jun 2022

Will the US overcome its covid complacency even as the threat returns?

A few months ago, it seemed as though the country was poised to finally tame the pandemic, after two years of restrictions and tens of billions in government spending.

15 Jun 2022

Buy and bust: When private equity comes for rural hospitals

When the new corporate owners of two rural hospitals suddenly announced they would stop admitting patients one Friday in March, Kayla Schudel, a nurse, stood resolute in the nearly empty lobby of Audrain Community Hospital: "You'll be seen; the ER is open."

15 Jun 2022

covid 19 News and Research

Research suggests profound SARS-CoV-2 mutations are rare even among immunosuppressed

Study confirms heightened protection from Omicron-associated hospitalizations by COVID boosters

Nasopharyngeal microbiota influences SARS-CoV-2 infection status and severity

Multiomics identifies genomic risk factors for COVID-19

Obesity causes COVID vaccines to lose their efficacy more rapidly

Study tracks neurological symptoms in COVID-19 "long-haulers"

Vaccination provides good but temporary protection against SARS-CoV-2 omicron infection, study shows

Evidence COVID in pregnancy can affect offspring's neurodevelopment

Countries with female leaders recorded fewer COVID-19 deaths, study finds

Loss of a grandmother may have repercussions for the loved ones she leaves behind

Implementing practical surface SARS-CoV-2 surveillance in public health labs and schools

Fc-effector functions for selecting COVID-19 convalescent plasma

People with mental health problems at higher risk for severe COVID-19 outcomes

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

More than 1,000 genes linked to severe COVID-19 identified

Flexible model of care can be effective in treating opioid use disorder

Survey data provides insights into how many students are experiencing long COVID

Affordable Advanced Rapid Diagnostics from Global Access Diagnostics (GADx)

Will the US overcome its covid complacency even as the threat returns?

Buy and bust: When private equity comes for rural hospitals

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News